abstract |
The present invention discloses compounds of formula (1), or pharmaceutically acceptable salts, esters or precursor drugs thereof, which inhibit Human Respiratory Syncytial Virus (HRSV) or inhibitors of Human Metapneumovirus (HMPV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from an HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. |